<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Park</surname>
    <given-names class="given-names">J. U.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kang</surname>
    <given-names class="given-names">B. Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lee</surname>
    <given-names class="given-names">H. J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kim</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Bae</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Park</surname>
    <given-names class="given-names">J. H.</given-names>
   </name>
   <etal class="etal"/>
  </person-group> (
  <year class="year">2017</year>). 
  <article-title class="article-title">Tetradecanol reduces EL-4 T cell growth by the down regulation of NF-kappaB mediated IL-2 secretion.</article-title>
  <source class="source">
   <italic class="italic">Eur. J. Pharmacol.</italic>
  </source>
  <volume class="volume">799</volume>
  <fpage class="fpage">135</fpage>â€“
  <lpage class="lpage">142</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ejphar.2017.02.002</pub-id>
  <?supplied-pmid 28167257?>
  <pub-id pub-id-type="pmid" class="pub-id">28167257</pub-id>
 </mixed-citation>
</ref>
